Lactobacillus paracasei strain
US-12152232-B2 · Nov 26, 2024 · US
Selection and use of lactic acid bacteria preventing bone loss in mammals
US10537598B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10537598-B2 |
| Application number | US-201916254994-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 23, 2019 |
| Priority date | Jun 4, 2012 |
| Publication date | Jan 21, 2020 |
| Grant date | Jan 21, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention comprises a method for selecting lactic acid bacterial strains effective for preventing bone loss in humans and strains that have been selected according to the presented method. The selection method is based on the strains capability of reestablishing an altered microbial community to normal and/or harboring at least one of four specific SNPs.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for preventing or treating bone loss, comprising administering to an individual in need thereof a lactic acid bacterial strain comprising a nucleic acid sequence having at least 99% identity to the nucleic acid sequence of the genome of L. reuteri JCM 1112 (SEQ ID NO:1), and wherein the lactic acid bacterial strain harbors a nucleotide relative to the genome of Lactobacillus reuteri JCM 1112 (SEQ ID NO: 1) in all of the following four positions: C in base pair 271 391, G in base pair 453 538, G in base pair 529 228, and C in base pair 599 338. 2. The method of claim 1 , wherein the bone loss is osteopenic and/or osteoporotic bone loss.
Assignees
Inventors
Classifications
for osteoporosis · CPC title
for bone diseases, e.g. rachitism, Paget's disease · CPC title
Drugs for skeletal disorders · CPC title
Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10537598B2 cover?
- The present invention comprises a method for selecting lactic acid bacterial strains effective for preventing bone loss in humans and strains that have been selected according to the presented method. The selection method is based on the strains capability of reestablishing an altered microbial community to normal and/or harboring at least one of four specific SNPs.
- Who is the assignee on this patent?
- Biogaia Ab, Univ Michigan State
- What technology area does this patent fall under?
- Primary CPC classification A61K35/747. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).